At the heart of the matter is the phosphorylation of specific serine and threonine residues in the aminoterminal region of β-catenin. Phosphorylation of these residues is essential for β-catenin binding to β-TRCP, and mutations affecting them are found in a variety of human tumors [11]. It had been presumed for many years that GSK3 catalysed these key phosphorylations, and that they were somehow interfered with by Wnt signaling [12] . The discovery of a GSK3-binding protein (GBP) that disrupted the association of GSK3 with Axin, and also bound to Dishevelled, conformed nicely with the prevailing model [13] . The target serines and threonines in β-catenin, each separated by three intervening residues, conform to consensus motifs for GSK3, and it was recently shown that Wnt signaling indeed modulates their phosphorylation [14] . Lurking in the shadows, however, was the complication that many GSK3 substrates require priming by another kinase that phosphorylates a serine/threonine four residues downstream of the GSK3 site. It was therefore proposed that the simultaneous binding of GSK3 and β-catenin to Axin might obviate the requirement for such priming [15] . After all, addition of Axin to test tubes containing β-catenin and GSK3 accelerated the rate of β-catenin phosphorylation [16] .
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The three new papers [8-10] on CKI illuminate the once shadowy area and make it clear that GSK3 does not act alone in setting up β-catenin for the kill. Although some differences exist between the results reported in these papers, all concur that serine 45 in β-catenin is phosphorylated by a CKI, and that this likely serves as a priming site for subsequent phos-phorylations by GSK3. Two reagents have made these discoveries possible -antibodies specific to sites of β-catenin phosphorylation, and RNA-mediated interference (RNAi). 
